Glaukos GKOS Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Glaukos in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Glaukos's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Glaukos's accounts receivable?
- Glaukos (GKOS) reported accounts receivable of $119.69M in Q1 2026.
- How has Glaukos's accounts receivable changed year-over-year?
- Glaukos's accounts receivable increased by 67.3% year-over-year, from $71.53M to $119.69M.
- What is the long-term trend for Glaukos's accounts receivable?
- Over 5 years (2020 to 2025), Glaukos's accounts receivable has grown at a 24.7% compound annual growth rate (CAGR), from $36.06M to $108.61M.
- What does accounts receivable mean?
- The amount of money customers owe the company for products already delivered.
- How do you interpret accounts receivable?
- An increasing trend relative to revenue may signal collection issues or a shift in customer payment terms.
- How does accounts receivable compare across companies?
- Varies by industry payment cycles; medtech companies often have longer cycles due to hospital procurement processes.